Company Filing History:
Years Active: 2013-2016
Title: Innovations of Anne-Claire Brehin
Introduction
Anne-Claire Brehin is a prominent inventor based in Paris, France. She has made significant contributions to the field of virology, particularly in relation to the Chikungunya virus. Her work has led to the development of innovative diagnostic products and potential vaccines.
Latest Patents
Anne-Claire Brehin holds 2 patents. Her latest patents include "Isolated and purified strains of Chikungunya virus and polynucleotides and polypeptides sequences, diagnostic and immunogenical uses thereof." This invention concerns wild strains of Chikungunya virus isolated from patients exhibiting severe forms of infection. It also involves polypeptide sequences derived from their genome, which can be used as diagnostic products, vaccines, and immunogenic compositions. Another significant patent is "Anti-chikungunya monoclonal antibodies and uses thereof." This invention focuses on anti-CHIK monoclonal antibodies and their application in detecting the presence of Chikungunya virus strains.
Career Highlights
Anne-Claire Brehin is affiliated with the Institut Pasteur, a renowned research institution known for its contributions to microbiology and infectious diseases. Her work at this prestigious institute has positioned her as a key figure in the fight against arboviral diseases.
Collaborations
Throughout her career, Anne-Claire has collaborated with notable colleagues, including Philippe Despres and Amadou Alpha Sall. These collaborations have further enhanced her research and innovation in the field.
Conclusion
Anne-Claire Brehin's contributions to virology and her innovative patents demonstrate her commitment to advancing medical science. Her work continues to have a significant impact on the understanding and treatment of Chikungunya virus infections.